Morten Ziebell

Summary

Affiliation: Neurobiology Research Unit
Country: Denmark

Publications

  1. ncbi Predictive value of dopamine transporter SPECT imaging with [¹²³I]PE2I in patients with subtle parkinsonian symptoms
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, Rigshospitalet and University of Copenhagen, N9201, 9 Blegdamsvej, Copenhagen DK 2100, Denmark
    Eur J Nucl Med Mol Imaging 39:242-50. 2012
  2. ncbi Evaluation of the superselective radioligand [123I]PE2I for imaging of the dopamine transporter in SPECT
    Morten Ziebell
    Department of Neurology, Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Dan Med Bull 58:B4279. 2011
  3. ncbi Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT
    Morten Ziebell
    Neurobiology Research Unit, Rigshospitalet, N9201, 9 Blegdamsvej, Copenhagen, 2100, Denmark
    Eur J Nucl Med Mol Imaging 34:101-9. 2007
  4. ncbi MRI-guided region-of-interest delineation is comparable to manual delineation in dopamine transporter SPECT quantification in patients: a reproducibility study
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    J Nucl Med Technol 38:61-8. 2010
  5. ncbi [Lewy body dementia]
    Morten Ziebell
    Neurobiologisk Forskningsenhed, Afdeling N 9201, Rigshospitalet, 2100 København Ø, Denmark
    Ugeskr Laeger 172:1675-8. 2010
  6. ncbi Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
    J Nucl Med 51:1885-91. 2010
  7. ncbi Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion
    Lars H Pinborg
    Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark
    J Nucl Med 46:1119-27. 2005
  8. ncbi Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studies
    Peter S Jensen
    Neurobiology Research Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Nucl Med Technol 39:271-8. 2011
  9. ncbi [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region
    Lars H Pinborg
    Neurobiology Research Unit, University of Copenhagen, N9201, Rigshospitalet, 9 Blegdamsvej, DK 2100 Copenhagen, Denmark
    Neuroimage 34:1450-3. 2007
  10. ncbi Experimental determination of the weighting factor for the energy window subtraction-based downscatter correction for I-123 in brain SPECT studies
    Robin de Nijs
    Department of Clinical Physiology, Nuclear Medicine, PET and Cyclotron Unit, Copenhagen University Hospital, Copenhagen, Denmark
    J Med Phys 35:215-22. 2010

Detail Information

Publications12

  1. ncbi Predictive value of dopamine transporter SPECT imaging with [¹²³I]PE2I in patients with subtle parkinsonian symptoms
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, Rigshospitalet and University of Copenhagen, N9201, 9 Blegdamsvej, Copenhagen DK 2100, Denmark
    Eur J Nucl Med Mol Imaging 39:242-50. 2012
    ..The study included consecutively enrolled, drug-naive patients with an average short history of parkinsonian motor symptoms, referred for diagnostic scanning...
  2. ncbi Evaluation of the superselective radioligand [123I]PE2I for imaging of the dopamine transporter in SPECT
    Morten Ziebell
    Department of Neurology, Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Dan Med Bull 58:B4279. 2011
    ..Apart from the more laborious B/I design it is currently to be considered the best radioligand for imaging the DAT in the human brain with SPECT...
  3. ncbi Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT
    Morten Ziebell
    Neurobiology Research Unit, Rigshospitalet, N9201, 9 Blegdamsvej, Copenhagen, 2100, Denmark
    Eur J Nucl Med Mol Imaging 34:101-9. 2007
    ....
  4. ncbi MRI-guided region-of-interest delineation is comparable to manual delineation in dopamine transporter SPECT quantification in patients: a reproducibility study
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    J Nucl Med Technol 38:61-8. 2010
    ..We also assessed the ability of the different approaches to identify striatal pathology in patients with parkinsonism...
  5. ncbi [Lewy body dementia]
    Morten Ziebell
    Neurobiologisk Forskningsenhed, Afdeling N 9201, Rigshospitalet, 2100 København Ø, Denmark
    Ugeskr Laeger 172:1675-8. 2010
    ..With new clinical criteria including SPECT of dopaminergic transporters, diagnosis has become sufficiently accurate to differentiate between the two diagnoses...
  6. ncbi Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
    J Nucl Med 51:1885-91. 2010
    ....
  7. ncbi Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion
    Lars H Pinborg
    Neurobiology Research Unit, University Hospital Rigshospitalet, Copenhagen, Denmark
    J Nucl Med 46:1119-27. 2005
    ....
  8. ncbi Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studies
    Peter S Jensen
    Neurobiology Research Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Nucl Med Technol 39:271-8. 2011
    ....
  9. ncbi [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region
    Lars H Pinborg
    Neurobiology Research Unit, University of Copenhagen, N9201, Rigshospitalet, 9 Blegdamsvej, DK 2100 Copenhagen, Denmark
    Neuroimage 34:1450-3. 2007
    ....
  10. ncbi Experimental determination of the weighting factor for the energy window subtraction-based downscatter correction for I-123 in brain SPECT studies
    Robin de Nijs
    Department of Clinical Physiology, Nuclear Medicine, PET and Cyclotron Unit, Copenhagen University Hospital, Copenhagen, Denmark
    J Med Phys 35:215-22. 2010
    ..A weighting factor of 1.1-1.2 can be applied in clinical practice. This correction effectively removes downscatter and significantly improves image contrast inside the brain...
  11. ncbi Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration
    Morten Ziebell
    Neurobiology Research Unit and Cimbi, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    Neurobiol Aging 33:428.e1-5. 2012
    ..01, R(2) = 0.36). We find that in patients with striatal dopaminergic neurodegeneration serum BDNF levels decrease along with loss in striatal DAT binding...
  12. ncbi Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease
    Asmus Vogel
    Memory Disorders Research Unit, Neuroscience Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
    Int J Geriatr Psychiatry 20:238-46. 2005
    ....